FDA Approves Merck’s Welireg (Belzutifan) for Renal Cell Carcinoma Treatment
-
Drug News
FDA Approves Merck’s Welireg (Belzutifan) for Renal Cell Carcinoma Treatment
In a significant development, the U.S. Food and Drug Administration (FDA) granted approval on Thursday for Merck’s drug belzutifan, marketed…
Read More »